Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation
byHarvard UniversityThe personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating
Updated on: January 28,2026
Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation
byHarvard UniversityThe personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating
Updated on:January 28,2026
